Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
Status:
Completed
Trial end date:
2020-11-02
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and
safety of DaxibotulinumtoxinA for injection (DAXI for injection) in the treatment of
Glabellar Lines (GL), Dynamic Forehead Lines (FHL), and Lateral Canthal Lines(LCL)